Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Radiation in the Treatment of Early Supraglottic Cancer-Reply

Radiation in the Treatment of Early Supraglottic Cancer-Reply Abstract In Reply.—There are a number of points in DeSanto's letter that require comment. We are unsure of DeSanto's intent in commenting on the selection of patients described in our article.1 Our article concerned early supraglottic carcinoma that we defined as stage T1 and T2 NO MO, and we naturally sought to compare patients so staged on clinical examination with those similarly staged and categorized in other reports. At no point did we state that "patients who in the beginning do not do well with irradiation are excluded and placed in a separate category," and in fact we did not do this. 2. The confusion about the number of patients in the Mayo Clinic series with positive neck nodes arose from our misinterpretation of the statement by Coates et al2 "that the 71 patients with NO cervical nodes clinically who were treated by initial neck dissection included two who at operation References 1. Harwood AR, Beale FA, Cummings BJ, et al: Management of early supraglottic carcinoma by irradiation with surgery in reserve . Arch Otolaryngol 1983;109:583-585.Crossref 2. Coates HL, De Santo LW, Devine KD, et al: Carcinoma of the supraglottic larynx . Arch Otolaryngol 1976;102:686-689.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Otolaryngology American Medical Association

Radiation in the Treatment of Early Supraglottic Cancer-Reply

Archives of Otolaryngology , Volume 110 (3) – Mar 1, 1984

Radiation in the Treatment of Early Supraglottic Cancer-Reply

Abstract

Abstract In Reply.—There are a number of points in DeSanto's letter that require comment. We are unsure of DeSanto's intent in commenting on the selection of patients described in our article.1 Our article concerned early supraglottic carcinoma that we defined as stage T1 and T2 NO MO, and we naturally sought to compare patients so staged on clinical examination with those similarly staged and categorized in other reports. At no point did we state that "patients who in...
Loading next page...
 
/lp/american-medical-association/radiation-in-the-treatment-of-early-supraglottic-cancer-reply-f6Q3071AXA
Publisher
American Medical Association
Copyright
Copyright © 1984 American Medical Association. All Rights Reserved.
ISSN
0003-9977
DOI
10.1001/archotol.1984.00800290072018
Publisher site
See Article on Publisher Site

Abstract

Abstract In Reply.—There are a number of points in DeSanto's letter that require comment. We are unsure of DeSanto's intent in commenting on the selection of patients described in our article.1 Our article concerned early supraglottic carcinoma that we defined as stage T1 and T2 NO MO, and we naturally sought to compare patients so staged on clinical examination with those similarly staged and categorized in other reports. At no point did we state that "patients who in the beginning do not do well with irradiation are excluded and placed in a separate category," and in fact we did not do this. 2. The confusion about the number of patients in the Mayo Clinic series with positive neck nodes arose from our misinterpretation of the statement by Coates et al2 "that the 71 patients with NO cervical nodes clinically who were treated by initial neck dissection included two who at operation References 1. Harwood AR, Beale FA, Cummings BJ, et al: Management of early supraglottic carcinoma by irradiation with surgery in reserve . Arch Otolaryngol 1983;109:583-585.Crossref 2. Coates HL, De Santo LW, Devine KD, et al: Carcinoma of the supraglottic larynx . Arch Otolaryngol 1976;102:686-689.Crossref

Journal

Archives of OtolaryngologyAmerican Medical Association

Published: Mar 1, 1984

References